Valneva ( ($VALN) ) just unveiled an update. On July 11, 2025, Valneva announced that the European Medicines Agency (EMA) lifted the temporary ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

The participants in the trial – similar to two-thirds of breast cancer patients overall - had tumors that use the hormones estrogen and progesterone to grow. The goal of so-called endocrine therapy is ...

The EMA has lifted restrictions on the chikungunya vaccine in people 65 and older, while warning that it should be used only ...

Controversial precautionary rules imposed last year for prescribing valproate to potentially fertile males are being assessed ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating people aged 65 ...

At its July meeting, the European Medicines Agency’s pharmacovigilance committee (PRAC) completed its review of French ...

EMA lifts suspension on Valneva's chikungunya vaccine for older adults, emphasizing its importance in high-risk situations.

The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...

Telangana: In a recent BSE filing, Gland Pharma has informed that the Pashamylaram Facility of the Company has received ...

Good Manufacturing Practices (GMP) are a system of processes, procedures, and documentation that ensures pharmaceutical ...

Europe's securities regulator warned crypto companies on Friday not to mislead customers about the extent to which their ...